Hyperbilirubinemia
Information
- Disease name
- Hyperbilirubinemia
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT02691156 | Completed | Bilirubin Binding Capacity to Assess Bilirubin Load in Preterm Infants | February 1, 2016 | August 31, 2018 | |
| NCT00004382 | Completed | Phase 2 | Phase II Study of Tin Mesoporphyrin vs Phototherapy for Hyperbilirubinemia in Premature Newborns | December 1999 | |
| NCT02774434 | Completed | N/A | Efficacy Study of the Draeger Jaundice Meter (JM-105) in Neonates of ≥ 24 Weeks of Gestational Age | November 2016 | June 2018 |
| NCT00115544 | Completed | Phase 2 | Safety and Pharmacology of Stanate | September 2005 | July 2006 |
| NCT00288600 | Completed | Phase 4 | Efficacy of High-dose Intravenous Immunoglobulin Therapy for Hyperbilirubinemia Due Rh Hemolytic Disease | October 2006 | August 2010 |
| NCT00360204 | Completed | Phase 3 | Improving Health Outcomes for New Mothers and Babies | September 2006 | February 2010 |
| NCT00383318 | Completed | Demographic, Metabolic, and Genomic Description of Neonates With Severe Hyperbilirubinemia | September 2006 | December 2007 | |
| NCT00635375 | Completed | N/A | Comparative Study of Phototherapy for Hyperbilirubinemia | March 2008 | August 2008 |
| NCT00653874 | Completed | Phase 3 | Transcutaneous Bilirubinometry in Healthy Term and Near-Term Neonates | November 2006 | August 2007 |
| NCT00004381 | Completed | Phase 2 | Phase II Randomized Study of Tin Mesoporphyrin for Neonatal Hyperbilirubinemia | December 1999 | |
| NCT04271098 | Completed | The Investigation of the Causes of Hepatic Dysfunction in the Postoperative Period During Open-heart Surgeries | January 1, 2012 | September 1, 2012 | |
| NCT01550627 | Completed | Early Phase 1 | Effect of Intravenous Fluid Supplementation on Serum Bilirubin and Cardiorespiratory Parameters in Preterm Infants During Phototherapy | November 2007 | June 2009 |
| NCT01622699 | Completed | N/A | Implementation of a Transcutaneous Bilirubinometer | October 2013 | May 2016 |
| NCT03195998 | Completed | Validity of Transcutaneous Bilirubin Monitoring in Preterm Infants | June 30, 2017 | February 1, 2019 | |
| NCT02446951 | Completed | Implementation of a Clinical Decision Rule for Treatment of Neonatal Jaundice in the Emergency Department | January 2015 | December 31, 2016 | |
| NCT02612207 | Completed | Point-of-Care System for Determination of Bilirubin Capacity in Neonates | August 1, 2015 | August 31, 2018 | |
| NCT02613676 | Completed | N/A | Transcutaneous Screening for Risk of Severe Hyperbilirubinemia in South African Newborns | August 2015 | October 2016 |
| NCT02805296 | Completed | N/A | High Intensity Phototherapy: Double vs. Single | June 2014 | August 2015 |
| NCT00076960 | No longer available | Compassionate Use of Stanate (TM) [Stannsoporfin] | |||
| NCT06421844 | Recruiting | A Prospective Study: Smart Phone Application for Measure Serum Bilirubin Through Sclera Images | April 20, 2024 | July 10, 2024 | |
| NCT03564678 | Recruiting | Phase 2 | Levocarnitine and Vitamin B Complex in Treating PEG-Asparaginase or Inotuzumab Ozogamicin-Induced Hyperbilirubinemia in Patients With Acute Lymphoblastic Leukemia | May 17, 2018 | December 31, 2036 |
| NCT02685189 | Terminated | Long-Term Clinical Follow-Up of Children Enrolled in Stannsoporfin Clinical Trial Protocol No. 64,185-06-2(W) | July 2006 | May 10, 2016 | |
| NCT00741117 | Terminated | N/A | Conjugated Hyperbilirubinemia and Pulse Oximetry | October 2011 | October 2011 |
| NCT01136577 | Terminated | N/A | Light-emitting Diodes (LED) Phototherapy for Hyperbilirubinemia of Term Newborn | January 2010 | March 2012 |
| NCT01944696 | Unknown status | N/A | Cycled Phototherapy: A Safer Effective Treatment for Small Premature Infants? | March 2014 | January 2018 |
| NCT04897113 | Unknown status | N/A | Study of Efficacy and Safety of the Plasmapheresis Method With Albumin Compensation Compared With the Plasmapheresis Method Without Albumin Compensation for Aging Biomarkers Correction in Men and Women Aged 40 to 55 Years Old | May 12, 2021 | December 30, 2022 |
| NCT02712138 | Withdrawn | Biomarker for Gilbert Disease (BioGilbert) | August 20, 2018 | February 28, 2021 |
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0002904
- OMIM Phenotype Series Number (OMIM)
- PS237450
- MedGen concept unique identifier (MedGen Concept name)
- C0020433
- MedGen unique identifier (MedGen Concept name)
- 6962
- MeSH unique ID (MeSH (Medical Subject Headings))
- D006932